Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| N-Acetylglucosaminyltransferases | 8 | 2024 | 22 | 2.280 |
Why?
|
| Host Cell Factor C1 | 5 | 2024 | 14 | 1.350 |
Why?
|
| Phosphatidylinositols | 2 | 2024 | 57 | 0.850 |
Why?
|
| Arrestins | 1 | 2022 | 14 | 0.810 |
Why?
|
| Biocatalysis | 2 | 2017 | 68 | 0.650 |
Why?
|
| Aspartic Acid | 1 | 2017 | 80 | 0.530 |
Why?
|
| Amides | 1 | 2016 | 91 | 0.500 |
Why?
|
| Antimycin A | 1 | 2014 | 13 | 0.460 |
Why?
|
| Salicylates | 1 | 2014 | 30 | 0.450 |
Why?
|
| Boron Compounds | 1 | 2014 | 22 | 0.450 |
Why?
|
| Lactones | 1 | 2014 | 55 | 0.440 |
Why?
|
| beta-Arrestins | 2 | 2024 | 15 | 0.440 |
Why?
|
| beta-Arrestin 1 | 2 | 2022 | 4 | 0.370 |
Why?
|
| Glycosylation | 5 | 2024 | 153 | 0.360 |
Why?
|
| Tetratricopeptide Repeat | 2 | 2024 | 2 | 0.240 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2024 | 3 | 0.240 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2025 | 46 | 0.230 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2025 | 40 | 0.230 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2024 | 207 | 0.230 |
Why?
|
| Parathyroid Hormone | 1 | 2024 | 106 | 0.220 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 827 | 0.210 |
Why?
|
| Mass Spectrometry | 1 | 2025 | 717 | 0.180 |
Why?
|
| Cell Membrane | 1 | 2024 | 734 | 0.180 |
Why?
|
| Receptors, Neurotensin | 1 | 2020 | 11 | 0.170 |
Why?
|
| Models, Molecular | 3 | 2020 | 1488 | 0.160 |
Why?
|
| Small Molecule Libraries | 2 | 2018 | 86 | 0.150 |
Why?
|
| Drug Design | 1 | 2018 | 158 | 0.140 |
Why?
|
| Proteolysis | 2 | 2014 | 167 | 0.130 |
Why?
|
| Molecular Conformation | 1 | 2017 | 141 | 0.130 |
Why?
|
| Hydrolysis | 1 | 2016 | 186 | 0.130 |
Why?
|
| HEK293 Cells | 3 | 2024 | 697 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 844 | 0.120 |
Why?
|
| Stereoisomerism | 1 | 2014 | 98 | 0.110 |
Why?
|
| Molecular Structure | 1 | 2014 | 483 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2024 | 4935 | 0.090 |
Why?
|
| Animals | 6 | 2025 | 35409 | 0.080 |
Why?
|
| Humans | 11 | 2025 | 129847 | 0.080 |
Why?
|
| Protein Binding | 2 | 2024 | 2123 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2025 | 1716 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 1708 | 0.060 |
Why?
|
| Electrophoresis, Capillary | 1 | 2025 | 20 | 0.060 |
Why?
|
| Clathrin | 1 | 2024 | 26 | 0.060 |
Why?
|
| Uridine Diphosphate N-Acetylglucosamine | 2 | 2015 | 4 | 0.060 |
Why?
|
| Single Molecule Imaging | 1 | 2024 | 36 | 0.060 |
Why?
|
| Diffusion | 1 | 2024 | 117 | 0.060 |
Why?
|
| Protein Domains | 1 | 2024 | 254 | 0.050 |
Why?
|
| Ligands | 1 | 2024 | 621 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 1086 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2021 | 371 | 0.040 |
Why?
|
| Protein Structure, Quaternary | 1 | 2020 | 121 | 0.040 |
Why?
|
| Protein Stability | 1 | 2020 | 162 | 0.040 |
Why?
|
| Peptides | 1 | 2024 | 926 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 178 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 76 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2018 | 109 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2021 | 457 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2024 | 2378 | 0.030 |
Why?
|
| Caseins | 1 | 2016 | 19 | 0.030 |
Why?
|
| Gram-Positive Bacteria | 1 | 2016 | 44 | 0.030 |
Why?
|
| Gram-Negative Bacteria | 1 | 2016 | 69 | 0.030 |
Why?
|
| Uridine Diphosphate | 1 | 2015 | 3 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 86 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2016 | 108 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 107 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 155 | 0.030 |
Why?
|
| Lectins | 1 | 2015 | 48 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2015 | 82 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 549 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 349 | 0.030 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2013 | 6 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 139 | 0.030 |
Why?
|
| Hydrogen Bonding | 1 | 2013 | 149 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 215 | 0.030 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2016 | 221 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2013 | 218 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 284 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 438 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 650 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 861 | 0.020 |
Why?
|